The Bristol Prostate Cancer Research Network (BPCRN) was established in 2010 in response to the need to improve the support within the NHS for prostate cancer research, and to ensure that research is better integrated with cancer care.
The brainchild of Professor David Gillatt (North Bristol NHS Trust / Bristol Urological Institute) the BPCRN brings together local consultants, scientists and researchers all experts in their field in investigating and treating prostate cancer.
The BPCRN has established robust partnerships and working relationships with several academic institutes and other NHS trust.
Our objectives are to:
- reduce the incidence of prostate cancer in the local community and nationwide by promoting research in discovery of new biomarkers for prostate cancer screening.
- increase the survival rate for prostate cancer patients.
- improve the quality of life of prostate cancer patients and their carers.
- provide a source of expertise ( national and international) on prostate cancer control for the government, NHS workforce and health service providers, medical researchers and the general public.